Company / EPS (Basic)
PULSE BIOSCIENCES, INC. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.92
FY2025
5-year range
-$2.14 / -$0.85
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#121 of 160
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s eps (basic) of $-0.92 is lower than 76% of companies in the Health Care sector (FY2025). Improved from $-1.72 to $-0.92 over the past 2 years.
Based on SEC 10-K filings.
-0.92 in FY2025.
Improved from $-1.72 to $-0.92 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 160This company -$0.92 Sector average $1.69
▼
-154.6% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 8.2% year-over-year.
- Ranks #121 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2024.
- Lowest eps (basic) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.92 | -8.2% |
| FY2024 | -$0.85 | +50.6% |
| FY2023 | -$1.72 | +19.6% |
| FY2022 | -$2.14 | - |
| FY2021 | - | - |
| FY2020 | -$2.14 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026